Access cutting-edge heart failure and reduced ejection fraction treatment through this clinical trial at a research site in Greenville. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Greenville location
Preparing your pre-screening questions…
Access heart failure and reduced ejection fraction specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related heart failure and reduced ejection fraction treatment provided free
Check if you qualify for this heart failure and reduced ejection fraction clinical trial in Greenville, NC
No-Cost Study Care
Local to Greenville
Convenient for NC residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Advanced heart failure, affecting 7 million Americans, has multiple causes and results in greatly increased risk of disability and death. A major problem is sudden cardiac death, when the damaged heart develops an abnormal pattern of electrical conduction that can result in cessation of heart activity. While placement of an Implantable Cardioverter-Defibrillator (ICD) in a patient's chest can help prevent sudden cardiac death, these devices have several important downsides. This protocol focuses on development of a digital decision aid that helps heart failure patients make informed decisions that balance the benefits and downsides of ICD placement. This protocol covers the use of participant surveys, focus groups, and interviews to obtain the needed background information to guide the development of this digital tool, which will be subsequently tested against usual care in a randomized clinical trial. The study design is best described as a mixed methods evaluation and refinement of a digital app to improve ICD decision-making. In the future, the present protocol will be modified to create a new protocol that covers the needed human subjects requirements for performance of this clinical trial.
Sponsor: Stanford University
Yes, this clinical trial (NCT07084142) has an active research site in Greenville, NC that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for heart failure and reduced ejection fraction treatment options in Greenville, NC, this clinical trial (NCT07084142) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Greenville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart failure and reduced ejection fraction specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all heart failure and reduced ejection fraction clinical trials near you to find additional studies recruiting in your area.
See all heart failure clinical trials recruiting in Greenville — not just this study.
Browse Heart Failure Trials in Greenville →